Skip to content 
Transcatheter aortic valve replacement (TAVR) is a minimally invasive procedure that is done to replace the aortic valve that has thickened/calcified due to various reasons, resulting in an inability to open completely. Thickening of the aortic valve is a serious condition, known as aortic valve stenosis, and it obstructs blood flow from the heart to the rest of the body.
Aortic valve stenosis can be caused by different reasons, including a congenital heart defect, calcium buildup in the valves and even rheumatic fever. This condition is often characterized by the following signs and symptoms:
- Irregularities in heartbeat
- Chest pain
- Dizziness or fainting
- Shortness of breath
- Fatigue
- Heart palpitations
- Reduced appetite and weight gain rate (in children mainly)
If not treated early on, aortic valve stenosis can lead to several medical complications, including heart failures. A TAVR procedure can help relieve these symptoms of aortic valve stenosis, while improving the blood flow in the heart and throughout the body.
Frequently Asked Questions
What is the recovery time for TAVR?
Recovery time varies depending on the patient, but most patients are able to leave the hospital within a day or two of the procedure. Full recovery typically takes 2 to 4 weeks.
Is TAVR a permanent solution?
Yes, TAVR is a permanent solution for aortic stenosis. The new valve should last for many years, though additional procedures may be necessary in the future.
Who is a candidate for TAVR?
Candidates for TAVR are typically elderly patients or those who are at high risk for complications from traditional open-heart surgery. A team of physicians will evaluate each patient to determine if TAVR is the appropriate treatment option.
Is TAVR covered by insurance?
Yes, TAVR is typically covered by insurance. However, coverage may vary depending on the patient’s insurance provider and specific plan.
What are the risks associated with TAVR?
As with any surgical procedure, there are risks associated with TAVR. These risks may include bleeding, infection, stroke, and damage to surrounding organs. However, the risks of TAVR are generally lower than those associated with traditional open-heart surgery.
